Tsai, M., Lin, Y., Chen, D., Lin, M., Wang, C., Hsieh, I., . . . Chen, T. (2024). Ticagrelor versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention. Clinical pharmacology and therapeutics, 116(3), 747-756. https://doi.org/10.1002/cpt.3209
Citácia podle Chicago (17th ed.)Tsai, Ming‐Lung, Yuan Lin, Dong‐Yi Chen, Ming‐Shyan Lin, Chao‐Yung Wang, I‐Chang Hsieh, Ning‐I Yang, Ming‐Jui Hung, a Tien‐Hsing Chen. "Ticagrelor Versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention." Clinical Pharmacology and Therapeutics 116, no. 3 (2024): 747-756. https://doi.org/10.1002/cpt.3209.
Citácia podľa MLA (8th ed.)Tsai, Ming‐Lung, et al. "Ticagrelor Versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention." Clinical Pharmacology and Therapeutics, vol. 116, no. 3, 2024, pp. 747-756, https://doi.org/10.1002/cpt.3209.